Magdalena aiming to submit Investigational New Drug application in 2024 to the FDA for this next-generation psychoactive prescription drug candidate for potential mental health indications such as ADHD, depression & anxietySAN FRANCISCO, CA / ACCES…

KELOWNA, BC / ACCESSWIRE / January 30, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that, on January 29, it submitted its much-anticipate…

Continued Nautobot Milestones Drive Increased Client Success, Company Growth, and Collective Innovation in Network AutomationNEW YORK, NY / ACCESSWIRE / January 30, 2024 / Network to Code, the global leader in Network Automation services and solutions,…

SANTA ANA, CA / ACCESSWIRE / January 30, 2024 / Nocturne Acquisition Corp. (NASDAQ:MBTCU) (the “Company”), announced today that the Board of Directors has voted in favor of postponing the meeting date for the Extraordinary General Meeting tha…

Seeking income and capital appreciation regardless of Fed policyDURANGO, CO / ACCESSWIRE / January 30, 2024 / Swan Global Investments and Index Provider O’Shares Investments join forces to launch the Swan Enhanced Dividend Income Strategy to provide in…

Parties will collaborate to support a complete and EU-compliant, life-cycle solution for lithium-based batteries deployed in the EU marketplaceSecond MOU executed by ReElement to refine recycled black mass sourced from the German market back to high-pu…

HERZLIYA, ISRAEL / ACCESSWIRE / January 30, 2024 / Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that kills the nerve cells controlling the voluntary movement of muscles. It is incurable and results in complete paralysis and…